Elicio Therapeutics, Inc. (ELTX) vs Elutia Inc (ELUT)
A side-by-side comparison of Elicio Therapeutics, Inc. and Elutia Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ELTX
Elicio Therapeutics, Inc.
$1.92HealthcareDelayed quote: Oct 6, 2026, 12:40 PM EDT
ELUT
Elutia Inc
$0.80HealthcareDelayed quote: Oct 6, 2026, 12:37 PM EDT
Total return — ELTX vs ELUT
growth of $100 · dividends reinvested · last 3yELTX -67.4% (-31.2%/yr)ELUT -44.1% (-17.6%/yr)ELUT compounded faster over this window
ELTX ELUT
ELTX vs ELUT: by the numbers
- •ELTX is the larger company ($37M vs $35M market cap).
- •ELUT is profitable (426.93% net margin) while ELTX runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | ELTX | ELUT |
|---|---|---|
| P/E ratio | N/A | 0.85 |
| P/S ratio | N/A | 2.90 |
| P/B ratio | 4.61 | 2.23 |
Profitability
| Metric | ELTX | ELUT |
|---|---|---|
| Gross margin | 0.00% | 57.82% |
| Operating margin | 0.00% | -149.78% |
| Net margin | 0.00% | 426.93% |
| ROE | -476.77% | 329.02% |
| ROIC | -171.36% | -79.27% |
Growth (annualized)
| Metric | ELTX | ELUT |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -22.04% |
| Total return CAGR (5Y) | N/A | -33.96% |
Frequently asked
- Is ELTX or ELUT more profitable?
- ELUT runs the higher net margin — ELTX at 0.00% versus ELUT at 426.93%.
Go deeper
Dig into the metrics
Elutia P/E ratioElicio Therapeutics ROEElutia ROEElicio Therapeutics operating marginElutia operating marginElicio Therapeutics revenue growthElutia revenue growthElicio Therapeutics free cash flowElutia free cash flow
Elicio Therapeutics & Elutia appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.